EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs

Mingwei Wei, Libai Lu, Zongjiang Luo, Jiasheng Ma, Jianchu Wang

BMC Gastroenterology · 2024

DOI: 10.1186/s12876-024-03219-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Mingwei Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise,…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Cuproptosis represents an innovative type of cell death, distinct from apoptosis, driven by copper dependency, yet the involvement of copper apoptosis-associated long non-coding RNAs (CRLncRNAs) in hepatocellular carcinoma (HCC) remains unclear. This study is dedicated to unveiling the role and significance of these copper apoptosis-related lncRNAs within the context of HCC, focusing on their impact on both the development of the disease and its prognosis.

Methods

We conducted an analysis of gene transcriptomic and clinical data for HCC cases by sourcing information from The Cancer Genome Atlas database. By incorporating cuproptosis-related genes, we established prognostic features associated with cuproptosis-related lncRNAs. Furthermore, we elucidated the mechanism of cuproptosis-related lncRNAs in the prognosis and treatment of HCC through comprehensive approaches, including Lasso and Cox regression analyses, survival analyses of samples, as well as examinations of tumor mutation burden and immune function.

Results

We developed a prognostic model featuring six cuproptosis-related lncRNAs: AC026412.3, AC125437.1, AL353572.4, MKLN1-AS, TMCC1-AS1, and SLC6A1-AS1. This model demonstrated exceptional prognostic accuracy in both training and validation cohorts for patients with tumors, showing significantly longer survival times for those categorized in the low-risk group compared to the high-risk group. Additionally, our analyses, including tumor mutation burden, immune function, Gene Ontology, Kyoto Encyclopedia of Genes and Genomes pathway enrichment, and drug sensitivity, further elucidated the potential mechanisms through which cuproptosis-associated lncRNAs may influence disease outcome.

Conclusions

The model developed using cuproptosis-related long non-coding RNAs (lncRNAs) demonstrates promising predictive capabilities for both the prognosis and immunotherapy outcomes of tumor patients. This could play a crucial role in patient management and the optimization of immunotherapeutic strategies, offering valuable insights for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCarcinoma, HepatocellularLiver NeoplasmsHumansPrognosisCopperApoptosisMaleBiomarkers, TumorFemaleGene Expression Regulation, NeoplasticTranscriptomeSurvival Analysis

Stichwörter der Autor:innen

Cuproptosis, lncRNAGenomicHCCImmune

Substanzen

RNA, Long NoncodingCopperBiomarkers, Tumor

Autor:innen und Institutionen

  • Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Baidong Hospital, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China. wjianchu@sina.com.
  • Department of Hepatobiliary and Pancreatic Surgery, Baidong Hospital, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China. wjianchu@sina.com.

Zitieren

APA

Wei, M., Lu, L., Luo, Z., Ma, J., & Wang, J. (2024). Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03219-6

Vancouver

Wei M, Lu L, Luo Z, Ma J, Wang J. Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03219-6

BibTeX
@article{Wei2024,
  author = {Wei, Mingwei and Lu, Libai and Luo, Zongjiang and Ma, Jiasheng and Wang, Jianchu},
  title = {Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs},
  journal = {BMC Gastroenterology},
  year = {2024},
  doi = {10.1186/s12876-024-03219-6}
}
Kostenlos starten →